Testing the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7040
Last updated 2017-05-02
Summary
Although most US adolescents visit their primary care doctor, their immunization rates are low. Primary care practices from two networks, one in upstate New York as well as a national network of pediatric clinics were surveyed to ask what they thought was the best strategy to increase immunization rates. Point-of-care prompts (either by an electronic health record message or by a nurse) when an adolescent patient comes in for any type of visit and is due for a vaccine was chosen. This study will determine if these prompts will increase immunization rates after a 12-month intervention period.
Conditions
- Vaccine Preventable Diseases
- Meningococcal Disease
- Human Papillomavirus
- Pertussis
- Influenza
Interventions
- OTHER
-
Point-of-Care Prompt
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
University of California, Los Angeles
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 11 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2013-01-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
Healthy, Immunized Communities Study
NCT03854734 ·Status: COMPLETED ·Phase: NA
-
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823 ·Status: COMPLETED ·Phase: NA
-
mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (D0271)
NCT03252288 ·Status: COMPLETED ·Phase: NA
-
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan
NCT03341195 ·Status: UNKNOWN ·Phase: NA
-
T-Cell Turnover Following Vaccination With MVA85A
NCT00548444 ·Status: COMPLETED ·Phase: PHASE1
-
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT06470919 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Antibiotics in Measles
NCT00168532 ·Status: COMPLETED ·Phase: PHASE3
-
Measles Vaccination Cash Incentives Experimental Evidence From Nigeria
NCT04013516 ·Status: COMPLETED ·Phase: NA
-
Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children
NCT03460002 ·Status: COMPLETED ·Phase: PHASE4
-
Bordetella Pertussis Carriage in College-aged Students
NCT02215564 ·Status: UNKNOWN
-
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
NCT05758532 ·Status: RECRUITING ·Phase: PHASE4
-
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
NCT06667206 ·Status: RECRUITING ·Phase: PHASE2
-
The Interaction Between Measles and DTP Vaccination
NCT02710045 ·Status: COMPLETED ·Phase: NA
-
Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
NCT03145324 ·Status: COMPLETED
-
Measles, Mumps, and Rubella (MMR) Immunity in College Students
NCT00962819 ·Status: COMPLETED
-
Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
NCT06616753 ·Status: RECRUITING
-
Measles Vaccination at Health System Contacts
NCT04220671 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
SMS Reminders to Improve the on Time Vaccination Rates Among Children in Pakistan
NCT01859546 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices
NCT01557699 ·Status: COMPLETED ·Phase: PHASE1
-
Missed Opportunities for Vaccine Equity
NCT04834960 ·Status: COMPLETED ·Phase: NA
-
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
NCT00395720 ·Status: COMPLETED ·Phase: PHASE1
-
EMaBS TB Vaccine Study
NCT03681860 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
NCT05803538 ·Status: UNKNOWN ·Phase: NA
-
Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.
NCT01694108 ·Status: COMPLETED ·Phase: PHASE4
-
Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial
NCT02904642 ·Status: COMPLETED ·Phase: NA